Bullish option flow detected in Aurinia Pharmaceuticals with 6,382 calls trading, 4x expected, and implied vol increasing over 1 point to 86.88%. Apr-24 18 calls and Feb-24 8 puts are the most active options, with total volume in those strikes near 2,300 contracts. The Put/Call Ratio is 0.32. Earnings are expected on February 27th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AUPH:
- Aurinia Pharmaceuticals sees FY24 net product revenue $200M-$220M
- Aurinia Pharmaceuticals sees FY23 revenue about $176M, consensus $174.71M
- Aurinia Pharmaceuticals sees Q4 revenue about $45M, consensus $44.2M
- Aurinia Pharmaceuticals submits IND application to FDA for AUR200
- Aurinia Pharmaceuticals put volume heavy and directionally bearish